STOCK TITAN
  1. Home
  2. Sec-filings
  3. AZN
  4. [CERT] ASTRAZENECA PLC Certification Filing

[CERT] ASTRAZENECA PLC Certification Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
CERT

Rhea-AI Filing Summary

Analyzing...
CERT - ASTRAZENECA PLC

CERT Filing - ASTRAZENECA PLC

This filing is available as a PDF document.

Filing Type: CERT

Company: ASTRAZENECA PLC (AZN)

Acceptance Date: 2026-01-22T16:28:47.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock AZN logo
Astrazeneca Plc

NASDAQ:AZN

AZN Rankings

#39 Ranked by Market Cap
N/A Ranked by Dividends

AZN Latest News

Jan 19, 2026
ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
Jan 13, 2026
TROPION-Lung17 TROP2 Biomarker Directed Phase 3 Trial of DATROWAY® Initiated in Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
Jan 8, 2026
Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit
Dec 22, 2025
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer
Dec 22, 2025
ENHERTU® Granted Breakthrough Therapy Designation in the U.S. as Post-Neoadjuvant Therapy for Patients with HER2 Positive Early Breast Cancer

AZN Latest SEC Filings

Jan 29, 2026
[6-K] ASTRAZENECA PLC Current Report (Foreign Issuer)
Jan 22, 2026
[CERT] ASTRAZENECA PLC Certification Filing
Jan 20, 2026
[6-K] ASTRAZENECA PLC Current Report (Foreign Issuer)
Jan 8, 2026
[6-K] ASTRAZENECA PLC Current Report (Foreign Issuer)
Dec 22, 2025
[6-K] ASTRAZENECA PLC Current Report (Foreign Issuer)

AZN Stock Data

296.41B
3.10B
0%
16.74%
0.25%
Drug Manufacturers - General
Healthcare
Link
United Kingdom
Cambridge